Fibclot

Human Fibrinogen (Fibclot) is a plasma-derived protein used to manage bleeding disorders. This intravenous treatment supports blood clotting and is essential for patients with fibrinogen deficiency.

Human Fibrinogen, marketed as Fibclot, is primarily used to treat bleeding episodes in patients with congenital fibrinogen deficiency. It is also utilized in surgical settings to control excessive bleeding. This medication works by replenishing fibrinogen levels in the blood, which is crucial for proper blood clotting. Patients with acquired deficiencies or those undergoing procedures that may cause significant blood loss may also benefit from this treatment.

Common effects of Human Fibrinogen may include localized reactions at the injection site, such as redness or swelling. Some individuals might experience mild fever or chills. These effects are generally temporary and subside quickly. Severe allergic reactions are rare but require immediate medical attention.

Human Fibrinogen should be administered under medical supervision. Patients with a history of allergic reactions to plasma-derived products should use this medication with caution. It is important to inform healthcare providers about any existing medical conditions or medications being taken to avoid potential complications.

Human Fibrinogen may interact with certain medications, including anticoagulants and antiplatelet drugs. Alcohol consumption should be avoided as it can affect the effectiveness of the treatment. Patients should consult their healthcare provider before starting any new medication while using Human Fibrinogen.